Safinamide in Parkinson's Disease: A retrospective study

被引：0
|
作者：
Carmona-Abellan, M.
Erburu, M.
Cabrera, A.
Garcia-Monco, C.
Berganzo, K.
Huete, B.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1378
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [41] A pilot study on the efficacy, tolerability and safety of safinamide in elderly Parkinson's disease patients
    Rinaldi, D.
    Sforza, M.
    Bianchini, E.
    Galli, S.
    Pontieri, F. E.
    MOVEMENT DISORDERS, 2020, 35 : S477 - S477
  • [42] Safinamide Improves Pain in Parkinson′s Disease. Results from the SAFINONMOTOR Study
    Yanez, R.
    Labandeira, C.
    Cimas Hernando, M.
    Cabo, I.
    Paz Gonzalez, J.
    Alonso Losada, M.
    Gonzalez Palmas, M.
    Martinez, C.
    Santos Garcia, D.
    MOVEMENT DISORDERS, 2021, 36 : S242 - S243
  • [43] Safinamide Improves Mood in Parkinson's Disease. Results from the SAFINONMOTOR Study
    Labandeira, C.
    Alonso Losada, M. G.
    Yanez Bana, R.
    Cimas Hernando, I.
    Cabo Lopez, I.
    Paz Gonzalez, J. M.
    Gonzalez Palmas, M. J.
    Martinez Miro, C.
    Santos Garcia, D.
    MOVEMENT DISORDERS, 2021, 36 : S218 - S218
  • [44] Safinamide improves executive functions in fluctuating Parkinson’s disease patients: an exploratory study
    Domiziana Rinaldi
    Michela Sforza
    Francesca Assogna
    Cinzia Savini
    Marco Salvetti
    Carlo Caltagirone
    Gianfranco Spalletta
    Francesco E. Pontieri
    Journal of Neural Transmission, 2021, 128 : 273 - 277
  • [45] The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
    Abbruzzese, Giovanni
    Barone, Paolo
    Lopiano, Leonardo
    Stocchi, Fabrizio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2507 - 2517
  • [46] Real life evaluation of safinamide effectiveness in Parkinson’s disease
    Francesca Mancini
    Alessio Di Fonzo
    Giulia Lazzeri
    Linda Borellini
    Vincenzo Silani
    Marco Lacerenza
    Cristoforo Comi
    Neurological Sciences, 2018, 39 : 733 - 739
  • [47] Spanish expert consensus on the use of safinamide in Parkinson's disease
    Valldeoriola, F.
    Grandas, F.
    Arbelo, J. M.
    Blazquez Estrada, M.
    Calopa Garriga, M.
    Campos-Arillo, V. M.
    Garcia Ruiz, P. J.
    Gomez Esteban, J. C.
    Leiva Santana, C.
    Martinez Castrillo, J. C.
    Mir, P.
    Salvador Aliaga, A.
    Vivancos Matellano, F.
    Yanez Bana, R. M.
    NEUROLOGIA, 2021, 36 (09): : 666 - 672
  • [48] The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease
    Perez-Lloret, Santiago
    Rascol, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (03) : 245 - 258
  • [49] A pilot study on the shift from rasagiline to safinamide in fluctuating Parkinson's disease patients
    Sforza, M. S.
    Pontieri, F. E.
    Rinaldi, D. R.
    Bianchini, E. B.
    MOVEMENT DISORDERS, 2020, 35 : S478 - S479
  • [50] Emerging approaches in Parkinson's disease - adjunctive role of safinamide
    Mueller, Thomas
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1151 - 1160
12345